Guillaume Cartron

机构：Centre National de la Recherche Scientifique, Université de Montpellier, Centre Hospitalier Universitaire de Montpellier, Institut de Génétique Moléculaire de Montpellier, Institut Universitaire de Recherche Clinique · ORCID：0000-0003-0659-9635

发表论文 620 篇 · 总被引 19180 次 · h-index 68

代表论文

• Combined PET and ctDNA response as a predictor of POD24 for follicular lymphoma after first-line induction treatment (2025 · Blood · 被引 13)
• Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry (2025 · Blood Advances · 被引 5)
• Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study (2025 · Blood Advances · 被引 5)
• Axi-cel delivers similar outcomes regardless of ASCT-eligibility in second line R/R LBCL: Combined data from ZUMA-7 and ALYCANTE (2025 · Blood · 被引 2)
• Three-Year Efficacy and Longitudinal Safety of Lisocabtagene Maraleucel (liso-cel) in Patients With Third-Line or Later (3L+) Follicular Lymphoma (FL) From TRANSCEND FL (2025 · Blood · 被引 2)
• Immunoglobulin G Receptors (FcγR), in Addition to Target-Antigen and Neonatal Fc Receptor (FcRn), Influence Rituximab Pharmacokinetics (2025 · Clinical Pharmacokinetics · 被引 2)